Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
story of the week
Published in Primary Care and
1 other channel

Journal Scan / Research · July 08, 2019

Effect of 1-Month DAPT Followed by Clopidogrel vs 12-Month DAPT on Cardiovascular and Bleeding Events in Patients Receiving PCI

JAMA: The Journal of the American Medical Association

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI

Peter Lin MD, CCFP

JAMA: The Journal of the American Medical Association
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial
JAMA 2019 Jun 25;321(24)2414-2427, H Watanabe, T Domei, T Morimoto, M Natsuaki, H Shiomi, T Toyota, M Ohya, S Suwa, K Takagi, M Nanasato, Y Hata, M Yagi, N Suematsu, T Yokomatsu, I Takamisawa, M Doi, T Noda, H Okayama, Y Seino, T Tada, H Sakamoto, K Hibi, M Abe, K Kawai, K Nakao, K Ando, K Tanabe, Y Ikari, KI Hanaoka, Y Morino, K Kozuma, K Kadota, Y Furukawa, Y Nakagawa, T Kimura

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated